Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Mehari

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Protein Engineering, Design & Selection : PEDS|April 16, 2026
Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugsAnna Mestre Borras, Hanna Mehari, Stefan Ståhl, et al.
Cell Reports Methods|June 11, 2025
Engineering high-efficiency matriptase substrates using E. coli display for applications in prodrug activationAnna Mestre Borras, Hanna Mehari, Stefan Ståhl, et al.
Cellular and Molecular Life Sciences : CMLS|June 24, 2026
Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockadeCornelia Westerberg, Chiara Sorini, Mariam Al-Haddad, et al.
Journal of Biological Engineering|June 9, 2026
Engineering a conditionally active cetuximab prodrug via affibody-based paratope maskingAnna Mestre Borras, Hanna Mehari, Athanasios Bitzios, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Protein Engineering, Design & Selection : PEDS|April 16, 2026
Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugsAnna Mestre Borras, Hanna Mehari, Stefan Ståhl, et al.
Cell Reports Methods|June 11, 2025
Engineering high-efficiency matriptase substrates using E. coli display for applications in prodrug activationAnna Mestre Borras, Hanna Mehari, Stefan Ståhl, et al.
Cellular and Molecular Life Sciences : CMLS|June 24, 2026
Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockadeCornelia Westerberg, Chiara Sorini, Mariam Al-Haddad, et al.
Journal of Biological Engineering|June 9, 2026
Engineering a conditionally active cetuximab prodrug via affibody-based paratope maskingAnna Mestre Borras, Hanna Mehari, Athanasios Bitzios, et al.
Pageof 1